Loading clinical trials...
Loading clinical trials...
The purpose of this observational study is to examine the clinical outcomes of the use of sirolimus as base therapy in kidney allograft recipients from Expanded Criteria Donors (ECD) under conditions ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT07294183 · Renal Transplantation
NCT06406179 · Renal Transplantation
NCT06674031 · Chronic Kidney Disease(CKD), Renal Transplantation
NCT06706492 · Renal Transplantation
NCT05086003 · Renal Transplantation
Pfizer Investigational Site
Caba, Buenos Aires
Pfizer Investigational Site
Caba, Buenos Aires
Pfizer Investigational Site
Caba, Buenos Aires
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions